Castle Biosciences (CSTL) Debt Ratio (2018 - 2026)

Castle Biosciences has disclosed Debt Ratio across 7 years of filings, most recently posting 0.02 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.02, down 8.1% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02 (down 8.1% YoY), and the FY2025 annual result was 0.02, down 7.87% from the prior year.
• Debt Ratio came in at 0.02 for Q1 2026 at Castle Biosciences, up from 0.02 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.05 in Q1 2022 to a low of 0.02 in Q4 2025.
• The 4-year median for Debt Ratio is 0.02 (2024), against an average of 0.02.
• Peak annual rise in Debt Ratio reached 7.87% in 2025, while the deepest fall reached 10.25% in 2025.
• Castle Biosciences' Debt Ratio stood at 0.05 in 2022, then slumped by 59.78% to 0.02 in 2024, then dropped by 7.87% to 0.02 in 2025, then rose by 5.71% to 0.02 in 2026.
• The last three Debt Ratio figures came in at 0.02 (Q1 2026), 0.02 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.